Literature DB >> 17450180

Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone.

R E Kast, D Focosi, M Petrini, E L Altschuler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17450180     DOI： 10.1038/sj.bmt.1705682

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?

Authors:  S Mornese Pinna; E Scarvaglieri; M G Milia; D Imperiale; V Ghisetti; S Audagnotto; A Prochet; F Lipani; S Bonora; G Di Perri; A Calcagno
Journal:  J Neurovirol       Date:  2017-07-05       Impact factor: 2.643

Review 2.  Update on PML: lessons from the HIV uninfected and new insights in pathogenesis and treatment.

Authors:  Elizabeth A Hartman; DeRen Huang
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

3.  Progressive multifocal leukoencephalopathy.

Authors:  Allen J Aksamit
Journal:  Curr Treat Options Neurol       Date:  2008-05       Impact factor: 3.598

Review 4.  Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.

Authors:  Dejan Pavlovic; Andriani C Patera; Fredrik Nyberg; Marianne Gerber; Maggie Liu
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.